Reliance for Emergency Use Authorization of Medicines and Other Health Technologies in a Pandemic (e.g. COVID-19)
Gov't Doc #
MetadataShow full item record
Purpose and Context: This document provides guidance to national regulatory authorities (NRAs) and regulatory systems on practical ways to implement reliance for emergency use of medicines and other health technologies in and around a pandemic. Note that countries use different terminologies for emergency use and the Pan American Health Organization (PAHO) will use the term “Emergency Use Authorization” (EUA). For the purposes of this document, medicines and other health technologies are defined to include pharmaceuticals, vaccines, and in Vitro Diagnostics (IVDs). Countries are encouraged to develop plans for regulatory preparedness and response in a pandemic including related to EUA of medicines and health technologies. This will afford an orderly and legal process to expedite the incorporation of these products into health systems. According to WHO guidance(1), country regulatory frameworks should include laws and/or policies that permit EUA for medicines and other health technologies, a pandemic preparedness plan that acknowledges EUA, technical procedures that use reliance and recognition on trusted/reference authorities for the EUA, and a system to monitor EUA products in the market. This document focuses on technical procedures for reliance to issue an EUA.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Regionalization as an approach to regulatory systems strengthening: a case study in CARICOM member states Preston, Charles; Chahal, Harinder S.; Porrás, Analia; Cargill, Lucette; Hinds, Maryam; Olowokure, Babatunde; Cummings, Rudolph; Hospedales, James (2016-05)Improving basic capacities for regulation of medicines and health technologies through regulatory systems strengthening is particularly challenging in resource-constrained settings. “Regionalization”—an approach in which ...
Crisis Management during an Epidemic: General guidelines for efficient response coordination by national regulatory authorities, May 2020 Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-05-08)Considering the advance of the COVID-19 (novel coronavirus SARS-CoV-2) pandemic and the resulting declarations of health emergencies in the countries of the Region of the Americas, it is necessary to clarify the role and ...
Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-06-05)This document provides national regulatory authorities (NRAs) with guidance for the regulation of clinical trials (CTs) in order to promote the investigation and use of safe and efficacious medicines and other health ...